Table 1 The upper part of the table shows a summary of the Patient and lesion-level characteristics of the training set.
Training patient-level characteristics | |||||||||
|---|---|---|---|---|---|---|---|---|---|
NV | MEL | SCC | BKL | BCC | AK | DF | VASC | Total | |
Patient | 4206 (34%) | 2857 (23%) | 431 (3%) | 1138 (9%) | 2809 (23%) | 737 (6%) | 124 (1%) | 111 (1%) | 12413 (100%) |
Male | 1946 (46%) | 1465 (51%) | 295 (68%) | 625 (55%) | 1683 (60%) | 367 (50%) | 59 (48%) | 59 (53%) | 6499 (52%) |
Female | 2219 (53%) | 1379 (48%) | 136 (32%) | 502 (44%) | 1120 (40%) | 367 (50%) | 65 (52%) | 52 (47%) | 5840 (47.5%) |
Not-reported | 41 (1%) | 13 (1%) | 0 (0%) | 11 (1%) | 6 (1%) | 3 (1%) | 0 (0%) | 0 (0%) | 74 (0.5%) |
Age | 43.4 ± 16 | 60.5 ± 16 | 72 ± 11 | 62.6 ± 15 | 65.5 ± 15 | 67.8 ± 13 | 50.4 ± 17 | 55.6 ± 17 | 56.8 ± 18 |
Lesion ___location | |||||||||
Anterior torso | 2346 (56%) | 1127 (39%) | 97 (23%) | 292 (25%) | 1049 (37%) | 91 (12%) | 39 (31%) | 45 (40%) | 5086 (41%) |
Up. extremity | 400 (9%) | 380 (13%) | 57 (13%) | 78 (7%) | 307 (14%) | 62 (8%) | 28 (23%) | 7 (6%) | 1319 (10%) |
Lo. extremity | 810 (19%) | 489 (17%) | 126 (29%) | 206 (18%) | 400 (11%) | 57 (8%) | 54 (44%) | 31 (28%) | 2173 (17%) |
Head/neck | 413 (10%) | 635 (22%) | 132 (31%) | 523 (46%) | 997 (36%) | 500 (69%) | 0 (0%) | 23 (21%) | 3233 (26%) |
Palms/soles | 156 (4%) | 195 (7%) | 13 (3%) | 7 (1%) | 0 (0%) | 6 (1%) | 0 (0%) | 3 (3%) | 380 (3%) |
Oral/genital | 24 (1%) | 19 (1%) | 0 (0%) | 14 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (2%) | 59 (1%) |
Not-reported | 57 (1%) | 12 (1%) | 6 (1%) | 18 (2%) | 56 (2%) | 21 (2%) | 3 (2%) | 0 (0%) | 173 (2%) |
Test Unknown subclass distribution | |||||||||
Nonprimary mel | Benign neoplasm | Scar | Infla-mmatory | Normal variant | Infectious disease | Other | |||
Count | 632 (30.98%) | 422 (20.69%) | 395 (19.36%) | 375 (18.38%) | 116 (5.69%) | 68 (3.33%) | 32 (1.57%) | ||
